Paul Holland, Foundation Capital partner, weighs in on market action, and BlackBerry's deal to buy Good Technology.» Read More
Max Wolff, Citizen V.C. chief economist; Yukari Kane, author of "Haunted Empire: Apple After Steve Jobs"; and David Nelson, Belpointe Asset Management.
A look at Apple's could-be deal with Beats Electronics, with CNBC's Morgan Brennan.
CNBC's Robert Frank reports on the race to be hip hop's first billionaire.
Discussing competition in the music streaming space, and what a potential deal between Apple and Beats Electronics could mean for the industry, with Elias Roman, Songza co-founder & CEO.
CNBC has learned Apple is in talks to buy headphone maker Beats Electronics for $3.2 billion. CNBC contributor Natalie Morris, and Peter Kafka, Re/code senior editor, discuss.
It's a huge departure for Tim Cook, says Matthew Garrahan, Financial Times media editor, discussing Apple's rumored attempt to acquire Beat Electronics for $3.2 billion.
Employees at Pfizer Inc's U.S. research centers may want to dust off their resumes if the company's proposed acquisition of Britain's AstraZeneca comes to fruition.
Nicholas Heyman, William Blair, discusses General Electric's possible acquisition of French train and power plant builder Alstom for more than $13 billion.
Sandy Villere, Villere Funds, shares his thoughts on Greenlight Capital's new stake in Conn's.
Eli Lilly Chairman & CEO John Lechleiter discusses his business' expansion of its animal health unit with the acquisition of Novartis' animal health business.
GlaxoSmithKline CEO Sir Andrew Witty, explains the large portfolio of vaccinations his company provides, and the value added from the company's acquisition of Novartis' vaccination business.
GlaxoSmithKline CEO Sir Andrew Witty, discusses the benefit to shareholders from his company's acquisition of Novartis' vaccination business, as well as its oncology unit.
Bob Moritz, PricewaterhouseCoopers chairman and senior partner, discusses the company's plan to boost its consulting business by extending its global reach.
Arne Sorenson, CEO & president of Marriott International, discusses his company's acquisition of the largest hotel company in Africa.
Michael Carr, Goldman Sachs M&A group in the Americas, shares his thoughts on the role of activists in deal making and the outlook for mergers and acquisitions.
Activism in the long-term is not only bad for shareholders but also bad for the economy as a whole, says Martin Lipton, Wachtell, Lipton, Rosen & Katz, expressing his views on shareholder activism. Also Lipton shares his thoughts on the two categories of hedge fund activism.
It's been a robust 12 months of mergers and buyouts. Here's an inside look at four high-profile deals from Facebook-WhatsApp to Warren Buffett's involvement with Heinz.
Discussing Facebook's decision to purchase virtual reality technology company Oculus VR for $2 billion, with Dennis Berman, The Wall Street Journal.
Discussing Facebook's decision to purchase virtual reality technology company Oculus for $2 billion, with Mike Isaac, Re/code senior editor.
Facebook purchased virtual reality technology company Oculus for $2 billion. Stephan Paterno, Slated CEO & co-founder, says Mark Zuckerberg is making an "offensive bet."